Initial recovery and rebound of type F intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin

29Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Investigational heptavalent botulinum antitoxin (HBAT) is now the primary antitoxin for US noninfant botulism patients. HBAT consists of equine Fab/F(ab')2 IgG fragments, which are cleared from circulation faster than whole immunoglobulins. Rebound botulism after antitoxin administration is not previously documented but occurred in our patient 10 days after HBAT administration. © 2011 The Author.

Cite

CITATION STYLE

APA

Fagan, R. P., Neil, K. P., Sasich, R., Luquez, C., Asaad, H., Maslanka, S., & Khalil, W. (2011). Initial recovery and rebound of type F intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin. Clinical Infectious Diseases, 53(9). https://doi.org/10.1093/cid/cir550

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free